Contents
Academy · Research Writing · Consolidated Standards Of Reporting Trials
CONSORT: The Consolidated Standards of Reporting Trials
CONSORT does not prescribe how a trial should be conducted. It requires authors to report, completely and in a fixed order, the trial that was actually conducted, so that readers can judge the evidence rather than rely on the authors’ summary.
CONSORT (Consolidated Standards of Reporting Trials) is a reporting guideline for the minimum information a randomised controlled trial report must contain so that readers, reviewers and future systematic reviewers can judge its design, conduct, analysis and findings. CONSORT 2025 provides a 30-item checklist and participant flow diagram for reporting randomised trials.
Learning objectives
- What CONSORT is a guideline for, and what it is explicitly not a guideline for.
- The structure of the 30-item CONSORT 2025 checklist and the participant flow diagram, and why the flow diagram is treated as mandatory in its own right.
- Which journals require CONSORT, and how editors and reviewers use the checklist in practice.
- What CONSORT extensions exist for, and when a trial needs one in addition to the main checklist.
Common misconceptions
- “CONSORT is about how to design or run a trial.” CONSORT is a reporting guideline, not a trial-conduct guideline; it specifies what must be disclosed in the published report, and deliberately does not prescribe methodological choices themselves.
- “The checklist alone is enough; the flow diagram is optional.” The CONSORT statement treats the patient-flow diagram as a required element alongside the 30-item checklist, because it is the only place that shows, numerically, who was excluded at each stage and why.
- “CONSORT applies to every trial design the same way.” The main CONSORT statement is written for two-group, parallel randomised trials; cluster, non-inferiority, pragmatic, and other designs each have a published CONSORT extension with additional or modified items.
Scope of CONSORT as a reporting guideline
The CONSORT 2010 Statement, published simultaneously in the BMJ, PLoS Medicine, Obstetrics & Gynecology, Open Medicine, Journal of Clinical Epidemiology and Annals of Internal Medicine, defines its own scope precisely: it is a set of recommendations for what information a report of a randomised controlled trial should contain, intended to allow readers to understand a trial's design, conduct, analysis and interpretation, and to assess the validity of its results1. It is explicitly a reporting standard, not a standard for how the trial itself must be designed or conducted: a well-conducted trial can be poorly reported, and CONSORT is intended to prevent such reporting deficiencies from concealing methodological problems or strengths from the reader.
The checklist and the flow diagram
CONSORT 2025 provides a 30-item checklist and participant flow diagram for reporting randomised trials. The earlier CONSORT 2010 checklist had 25 items spanning the title and abstract, introduction, methods (trial design, participants, interventions, outcomes, sample size, randomisation, blinding, statistical methods), results (participant flow, numbers analysed, outcomes and estimation, ancillary analyses, harms), and discussion1. Alongside the checklist, CONSORT specifies a required participant-flow diagram showing, at each stage of the trial (enrolment, allocation, follow-up, analysis), how many participants were assessed, randomised, received the intended intervention, were lost to follow-up (with reasons) and were included in the final analysis. The flow diagram is not supplementary; the statement treats it as essential because it is the only element that shows numerically how the analysed sample relates to all participants originally assessed.
Use of CONSORT by journals and reviewers
Hundreds of biomedical journals, including those that co-published the 2010 statement, require authors to submit a completed CONSORT checklist with a trial manuscript, mapping each item to the page or section in which it is addressed. Editors and peer reviewers use the submitted checklist as a direct cross-check: if an item is declared as reported but cannot be found at the stated location, this is treated as a reporting deficiency, separate from any judgement about the underlying quality of the trial. For this reason, CONSORT compliance is assessed item by item rather than as an overall impression; the checklist format is designed specifically to make the cross-check systematic.
Extensions for designs beyond the base checklist
The base CONSORT statement is written for the most common trial design — individually randomised, two-group, parallel trials1. The CONSORT group has published a series of extensions for designs and circumstances the base checklist does not fully cover, including cluster-randomised trials, non-inferiority and equivalence trials, pragmatic trials, and trials of non-pharmacologic treatments, among others. A trial that uses one of these designs is expected to report against the base checklist plus the relevant extension's additional or modified items, not the base checklist alone.
Key points
Key points
CONSORT is a reporting standard, not a design standard: it specifies, item by item, what a randomised trial report must contain, including a mandatory flow diagram, so that readers can judge the validity of the trial directly from the published text rather than relying on the authors’ summary.
Practical application
Practical application
- The manuscript should be mapped against the 30-item CONSORT 2025 checklist before submission. A checklist mapped to page numbers should be produced, as most target journals require, and any item that cannot be located in the draft should be treated as a gap to be remedied rather than a formality.
- The flow diagram should be constructed from trial records rather than from memory. Enrolment, allocation, follow-up and analysis numbers should be reconstructed directly from the trial database or site logs, with documented reasons for every exclusion and loss to follow-up.
- Whether an extension applies should be determined before the results are drafted. The trial design (cluster, non-inferiority, pragmatic or other) should be checked early against the published list of CONSORT extensions, since several extension items affect the structure, not only the wording, of the methods and results sections.
Frequently asked questions
No. CONSORT is specifically for randomised controlled trials; other designs have their own reporting guidelines (for example STROBE for observational studies, or PRISMA for systematic reviews).
No, although several CONSORT items overlap with information that risk-of-bias tools also require (such as allocation concealment and blinding). CONSORT is a reporting completeness checklist; a separate risk-of-bias assessment tool is used to judge methodological quality.
Typically the manuscript is returned for revision with specific missing items identified; CONSORT non-compliance is usually treated as a reporting deficiency to be corrected before review proceeds, rather than an automatic rejection, though practice varies by journal.
References
- Schulz KF, Altman DG, Moher D, for the CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332. read 10 October 2026. View on The BMJ
- Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869. read 10 October 2026. View on The BMJ
Every source above is a peer-reviewed article, a publisher’s record of one, or a standard issued by the body that owns it. Each carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.
How to cite this article
Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.
Pubrica Academy. (2026, October 10). CONSORT: The Consolidated Standards of Reporting Trials. Pubrica. https://pubrica.com/academy/concepts-definitions/consolidated-standards-of-reporting-trials/
Pubrica Academy. “CONSORT: The Consolidated Standards of Reporting Trials.” Pubrica, 10 Oct. 2026, pubrica.com/academy/concepts-definitions/consolidated-standards-of-reporting-trials/.
Pubrica Academy (2026) CONSORT: The Consolidated Standards of Reporting Trials. Pubrica. Available at: https://pubrica.com/academy/concepts-definitions/consolidated-standards-of-reporting-trials/ (Accessed: 15 October 2026).
Pubrica Academy. “CONSORT: The Consolidated Standards of Reporting Trials.” Pubrica. October 10, 2026. https://pubrica.com/academy/concepts-definitions/consolidated-standards-of-reporting-trials/
Pubrica Academy, ‘CONSORT: The Consolidated Standards of Reporting Trials’ (Pubrica, 10 October 2026) <https://pubrica.com/academy/concepts-definitions/consolidated-standards-of-reporting-trials/> accessed 15 October 2026.
Pubrica Academy. CONSORT: The Consolidated Standards of Reporting Trials. [Internet]. Pubrica; 2026 Oct 10 [cited 2026 Oct 15]. Available from: https://pubrica.com/academy/concepts-definitions/consolidated-standards-of-reporting-trials/
Pubrica Academy, “CONSORT: The Consolidated Standards of Reporting Trials,” Pubrica, Oct. 10, 2026. [Online]. Available: https://pubrica.com/academy/concepts-definitions/consolidated-standards-of-reporting-trials/
@misc{consort_reporting_trials_2026,
author = {{Pubrica Academy}},
title = {CONSORT: The Consolidated Standards of Reporting Trials},
howpublished = {Pubrica},
year = {2026},
month = {oct},
url = {https://pubrica.com/academy/concepts-definitions/consolidated-standards-of-reporting-trials/},
note = {Accessed: <span data-cite-acc="iso">2026-10-15</span>}
}This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.
CONSORT pre-submission checklist stub
Each item should be mapped to a page or section number in the draft before submission.
Item 1 Title/abstract: identification as randomised trial -- page __ Item 3 Trial design -- page __ Item 6 Outcomes (primary/secondary, pre-specified) -- page __ Item 8 Randomisation: sequence generation -- page __ Item 10 Allocation concealment mechanism -- page __ Item 13 Participant flow diagram included -- Y/N Item 17 Outcomes and estimation -- page __ [continue for all 30 CONSORT 2025 items against the full published checklist]
Pubrica AcademyWritten and maintained by Pubrica’s subject matter experts. Articles are revised when the underlying standards change, and each article states the date on which it was last reviewed.
How Pubrica can help
Pubrica’s medical-writing team builds the page-mapped CONSORT checklist and the participant-flow diagram directly from trial records, and reviews the draft manuscript item by item before submission, so that reporting gaps are identified before editorial assessment.